I am Julia Camps Herrero, a breast radiologist for more than 20 years and I currently hold the position of Corporate Head of the Breast Area in the Ribera Group hospitals since 2019, leading a transversal and innovative project that integrates the work of all professionals dedicated to breast pathology in five hospitals.

I studied at the Faculty of Medicine of Valencia and later I trained as a radiologist at the General Hospital of Alicante, complementing my training at the Massachusetts General Hospital in Boston for 6 months. At the end of the specialty, I started working as a general radiologist at the Verge Dels Lliris Hospital in Alcoi and later I moved to the Ribera de Alzira University Hospital from 1999 to 2019 where I subspecialized in abdominal radiology and breast radiology, performing the position of Chief Radiology Service from 2006 to May 2019.

Since 1999 I have dedicated myself to clinical breast research, integrating all diagnostic techniques in collaboration with all specialists in the Breast Area, with special interest in breast MRI, contrast-enhanced mammography and minimally invasive interventional techniques. (vacuum assisted biopsies). I am currently interested in the application of radiomics (advanced image analysis) to precision medicine.

I have been an invited speaker in Latin America and Europe in more than 350 presentations. I am the author of 21 original articles, 11 book chapters, and 75 posters and oral communications related to Breast. I have actively participated in numerous scientific committees: I have been the president of the Breast committee at the European Congress of Radiology in 2012, of the scientific committee at the Spanish Breast Congress in 2015, and I have been a member of various scientific committees in Spain. , Europe and Latin America during the last 15 years. I am currently the vice-president of the Spanish Society of Breast Imaging (SEDIM) and from 2018 to 2020, I was the president of the European Society of Breast Radiology (EUSOBI).

What inspires me: using diagnostic breast imaging techniques to help personalize treatment for each patient under the motto "less is more", that is, demonstrating that diagnostic and interventional techniques of breast radiology can help define which patients are whether or not they will benefit from treatments such as surgery, radiotherapy or chemotherapy.

I am Lorenzo Rabadán, surgical coordinator of the Breast Area of ​​the Ribera health group. I have been dedicated to the treatment of patients with breast cancer for more than 20 years, in multidisciplinary units, always seeking to offer women the highest quality, in a humane and safe environment and with special attention to their integral well-being throughout the process.

Each patient is unique and each case, a challenge. But my goal always, in addition to working for the total recovery of patients, is to approach oncoplastic surgery for breast cancer with the least possible alteration of the woman's body image, thus facilitating a quick recovery and her return to personal life. , family and work.

In addition, I am the coordinator of the Breast Unit of the Torrejón University Hospital, managed by the Ribera group but belonging to the Hospital Network of the Madrid Health Service. Since the opening of this hospital, in October 2011, I have been responsible for the design and management of its Breast Unit, where the entire team shares the same values ​​and works every day with closeness, humanity and dedication to service, prioritizing personalized attention. to patients and families whenever they need it.

My strong commitment to the patients who face this pathology, the commitment to excellence and the humane and close treatment have also led me to assume the Presidency of the Breast and Gynecological Tumors Committee of this hospital, and also, I am the secretary of the Oncology Commission of the Hospital.

These same values ​​are what encouraged me to assume the Coordination of the Breast Pathology Section of the Spanish Association of Surgeons until January 2021, where I currently maintain my relationship as an advisor to the Board of Directors. I am also a member of the Spanish Society of Senology and Breast Pathology and the Spanish Association of Breast Surgeons (AECIMA), as well as director of the Master's Degree in Breast Surgery of the Spanish Association of Surgeons-Editorial Panamericana, coordinator of the Course of Breast Pathology, Oncoplastic Surgery and Reconstruction of the Spanish Association of Surgeons, based at the Torrejón Hospital and Associate Professor of Medicine at the Francisco de Vitoria University.

I am Laia Bernet, a pathologist for more than 20 years. For some years now, I have been lucky enough to be able to dedicate myself specifically to breast pathology, which has allowed me to go deeper into the diagnosis, both from the morphological, genetic and molecular point of view to advance in the understanding of some of the alterations that underlie cancer and, consequently, improve the indications for new therapeutic opportunities.

I was a pioneer in Europe in the OSNA technique for the intraoperative diagnosis of the sentinel node, in the 90s. Since then, I have not stopped working in the area of ​​the breast, incorporating new techniques and procedures and leading different research projects, some of them they financed by institutional or governmental scholarships.

All this has allowed me not only to publish in impact journals, direct doctoral theses, be part of the European group of experts in breast cancer (EBCWG), the editorial committee of some scientific journals and the Board of Directors of the Spanish Society of Senology. and Breast Pathology (SESPM) but also, in daily clinical work, being part of a great team with the best professionals.

Currently, I continue working in the area of ​​breast pathology and advancing in precision pathology, essential both to avoid over-treatment and to offer new therapeutic opportunities in each phase of the disease.

I thank all patients for the opportunity to offer my work and effort.

Dr. Javier Cortés Castán is a leading oncologist in the research and treatment of breast cancer of recognized international prestige. He is the author of more than 300 international publications, especially on breast cancer, being the only Spaniard to have two publications in the CA journal: a Cancer Journal for Clinicians, the medical journal with the highest impact factor in the world. He has also presented more than 600 conferences in different international congresses. He has been very actively involved in the clinical trials that have led to the approval of seven new treatments for metastatic breast cancer in Europe over the last decade and is highly engaged in research against this tumor, especially the triple subtypes. negative and HER2-positive. He is part of more than 150 scientific projects related to this disease, with a leadership position in many of them. He is a reviewer for several top-level medical journals, such as the New England Journal of Medicine, Lancet, Lancet Oncology, Annals of Oncology, or Journal of Clinical Oncology, among many others. He is also an active member of the Spanish, European and American Medical Oncology Societies (SEOM, ESMO, ASCO). In addition, he is a member of the Scientific Committee of the European Society for Medical Oncology (ESMO), he has been chair for breast cancer at the ESMO 2020 congress, and co-chair of the same section at the congress of the American Association for Cancer Research. Cancer (AACR) 2020 and also from the immunotherapy area of ​​the AACR 2021 congress.